• email
  • rss
  • twitter
  • facebook
  • linkedin
  • News
  • Investors
  • Contact

Ceapro Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Quality Management System
    • Sustainability
  • Technologies
    • Overview
    • Ethanol Fractionation Processes
    • Pressurized Gas Expanded (PGX) Technology
    • Chromatography Purification
    • Intellectual Property
    • Scientific Publications
  • Pipeline
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
    • Product Brochures
  • Cosmeceuticals
    • Overview
  • Nutraceuticals
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
  • Business Development
    • Overview
    • Partners
  • News
  • Investors
  • Contact
  • Home
  • Investors
  • News / Events
  • Press Releases
Navigation
  • Overview
  • News / Events
    • Press Releases
    • Events
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • Corporate Governance
  • SEDAR
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007

Ceapro Signs Agreement With Gamma-Dynacare Medical Laboratories for Diabetes Test, CeaProve(R)

November 14, 2007

Ceapro: Rapid Diabetes Risk Assessment Test Now in Production

November 13, 2007

CeaProve(R) Screening Test Meal Set to Make Waves at Diabetes Conference

October 24, 2007

Ceapro: Issuance of Stock Options

September 25, 2007

Ceapro Inc.: Glenn Rourke Joins Ceapro Board

September 25, 2007

Ceapro Boosting Investment in High Technology at New Facility, Announces Improved Refinancing

September 24, 2007

Gilles Gagnon Joins Ceapro Board

September 11, 2007

Ceapro Growth Continues: First Six Months and Q2 Sales Maintain Operational Profitability

August 29, 2007

Ceapro Launches Superior Care for Man's Best Friend in U.S. Market

April 18, 2007

RSS

Sign up for email ALERTS Be the first to receive news and updates on Ceapro. Sign Up

  • © 2023 Ceapro Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap